These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32527506)

  • 1. Attitudes about medications for alcohol use disorder among individuals with serious mental illness: A health belief model analysis.
    Bromley E; Tarn DM; McCreary M; Hurley B; Ober AJ; Watkins KE
    J Subst Abuse Treat; 2020 Jul; 114():108007. PubMed ID: 32527506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication prescribing for alcohol use disorders during alcohol-related encounters in a Colorado regional healthcare system.
    Chockalingam L; Burnham EL; Jolley SE
    Alcohol Clin Exp Res; 2022 Jun; 46(6):1094-1102. PubMed ID: 35723682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medications for alcohol use disorder improve survival in patients with hazardous drinking and alcohol-associated cirrhosis.
    Rabiee A; Mahmud N; Falker C; Garcia-Tsao G; Taddei T; Kaplan DE
    Hepatol Commun; 2023 Apr; 7(4):. PubMed ID: 36972386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using a cascade of care framework to identify gaps in access to medications for alcohol use disorder in British Columbia, Canada.
    Socias ME; Scheuermeyer FX; Cui Z; Mok WY; Crabtree A; Fairbairn N; Nolan S; Slaunwhite A; Ti L
    Addiction; 2023 Nov; 118(11):2128-2138. PubMed ID: 37488683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Availability of Medications for Alcohol Use Disorder Treatment in Medicare Part D, 2014-2018.
    Harris SJ; Abraham AJ; Yarbrough CR
    J Stud Alcohol Drugs; 2022 Sep; 83(5):653-661. PubMed ID: 36136435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addiction Consult Service and Inpatient Outcomes Among Patients with Alcohol Use Disorder.
    Singh-Tan S; Torres-Lockhart K; Jakubowski A; Lu T; Starrels J; De Lima P; Arnsten J; Nahvi S; Southern W
    J Gen Intern Med; 2023 Nov; 38(14):3216-3223. PubMed ID: 37100986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescribing Medications for Alcohol Use Disorder: A Qualitative Study of Primary Care Physician Decision Making.
    Bhardwaj A; Sousa JL; Huskamp HA; Busch AB; Kennedy-Hendricks A; Hodgkin D; Horgan C; Uscher-Pines L
    Ann Fam Med; 2023; 21(4):332-337. PubMed ID: 37487716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Availability of Medications for the Treatment of Alcohol Use Disorder in U.S. Counties, 2016-2019.
    Abraham AJ; Yarbrough CR
    J Stud Alcohol Drugs; 2021 Nov; 82(6):689-699. PubMed ID: 34762028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes After Initiation of Medications for Alcohol Use Disorder at Hospital Discharge.
    Bernstein EY; Baggett TP; Trivedi S; Herzig SJ; Anderson TS
    JAMA Netw Open; 2024 Mar; 7(3):e243387. PubMed ID: 38551564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initiation of Medication for Alcohol Use Disorder for Inpatients with Alcohol Withdrawal Syndromes.
    Krimpuri R; Youngs C; Emerman C
    J Stud Alcohol Drugs; 2023 Mar; 84(2):293. PubMed ID: 36971765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment for alcohol-related problems: special populations: research opportunities.
    Gomberg ES
    Recent Dev Alcohol; 2003; 16():313-33. PubMed ID: 12638644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of initiation of and retention on medications for alcohol use disorder among people living with and without HIV.
    Oldfield BJ; McGinnis KA; Edelman EJ; Williams EC; Gordon AJ; Akgün K; Crystal S; Fiellin LE; Gaither JR; Goulet JL; Korthuis PT; Marshall BDL; Justice AC; Bryant K; Fiellin DA; Kraemer KL
    J Subst Abuse Treat; 2020 Feb; 109():14-22. PubMed ID: 31856946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medications for alcohol use disorder promote abstinence in alcohol-associated cirrhosis: Results from a systematic review and meta-analysis.
    Gratacós-Ginès J; Bruguera P; Pérez-Guasch M; López-Lazcano A; Borràs R; Hernández-Évole H; Pons-Cabrera MT; Lligoña A; Bataller R; Ginès P; López-Pelayo H; Pose E
    Hepatology; 2024 Feb; 79(2):368-379. PubMed ID: 37625154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organizational Capacity and Readiness to Provide Medication for Individuals with Co-Occurring Alcohol Use Disorders in Public Mental Health Settings.
    Watkins KE; Hunter SB; Cohen CC; Leamon I; Hurley B; McCreary M; Ober AJ
    Adm Policy Ment Health; 2021 Jul; 48(4):707-717. PubMed ID: 33387128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel human laboratory model for screening medications for alcohol use disorder.
    Ho D; Towns B; Grodin EN; Ray LA
    Trials; 2020 Nov; 21(1):947. PubMed ID: 33225963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National outpatient medication utilization for opioid and alcohol use disorders from 2014 to 2016.
    Evoy KE; Roccograndi L; Le S; Leonard CE; Covvey JR; Ochs L; Peckham AM; Soprano SE; Reveles KR
    J Subst Abuse Treat; 2020 Dec; 119():108141. PubMed ID: 33138926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlates of Aggression in Men With Methamphetamine Use Disorder: Childhood Trauma and Methamphetamine-Use Characteristics.
    Liu M; Pu L; Liu T; Zhang X; Shen H; Deng Q; Wang Y; Li W; Fu X; Yang C; Fang T; Potenza MN; Hao W
    Front Psychiatry; 2022; 13():888055. PubMed ID: 35669272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship Between Primary Care Providers' Perceptions of Alcohol Use Disorder And Pharmacotherapy Prescribing Rates.
    Bernstein EY; Pfoh ER; Le P; Rothberg MB
    Alcohol Alcohol; 2023 Jan; 58(1):54-59. PubMed ID: 36368012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inpatient adoption of medications for alcohol use disorder: A mixed-methods formative evaluation involving key stakeholders.
    Joudrey PJ; Oldfield BJ; Yonkers KA; O'Connor PG; Berland G; Edelman EJ
    Drug Alcohol Depend; 2020 Aug; 213():108090. PubMed ID: 32559667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advancing Precision Medicine for Alcohol Use Disorder: Replication and Extension of Reward Drinking as a Predictor of Naltrexone Response.
    Witkiewitz K; Roos CR; Mann K; Kranzler HR
    Alcohol Clin Exp Res; 2019 Nov; 43(11):2395-2405. PubMed ID: 31436886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.